Treatment of advanced or metastatic triple negative breast cancer with tumor infiltrating lymphocytes (TILs).
The TILS001 trial
Phase 1 other active
Quick answer
Treatment of advanced or metastatic triple negative breast cancer with tumor infiltrating lymphocytes (TILs). for advanced or metastasic triple-negative breast cancer is a Phase 1 program (other) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- advanced or metastasic triple-negative breast cancer
- Phase
- Phase 1
- Modality
- other
- Status
- active